Clinical Trials Directory

Trials / Unknown

UnknownNCT05906719

Machine Vision Based MDS-UPDRS III Machine Rating

Machine Vision Based Machine Rating of MDS-UPDRS III

Status
Unknown
Phase
Study type
Observational
Enrollment
871 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The Movement Disorders Society (MDS) Unified Parkinson's Disease Rating Scale (UPDRS) Part III (MDS-UPDRS III) is the primary assessment method for motor symptoms in Parkinson's disease patients. Currently, movement disorder specialists conduct semi-quantitative scoring, which entails limitations such as subjectivity, weak sensitivity, and a limited number of professional physicians. This study, based on machine vision, establishes gold standard labels according to expert scoring. By using machine learning, we develop a machine rating model and compare the model's performance with gold standard rating and general clinical rating to investigate the accuracy of machine vision-based MDS-UPDRS III machine rating.

Conditions

Interventions

TypeNameDescription
OTHERvideo recordingPatients' performance of MDS-UPDRS III will be recorded.

Timeline

Start date
2023-03-01
Primary completion
2024-04-01
Completion
2024-04-01
First posted
2023-06-18
Last updated
2023-06-18

Locations

8 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05906719. Inclusion in this directory is not an endorsement.